Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Merck Appoints Board Member Thomas H. Glocer As Independent Lead Director Effective Immediately

By John F. Heerdink, Jr.

Reportedly, the board of Merck & Co., Inc. (MRK) announced the appointment of Thomas H. Glocer as independent lead director effective immediately. Mr. Glocer has served on the Merck Board of Directors since 2007 and has extensive management, technology, operational, and international business expertise, including his history of achievement and executive leadership while serving as chief executive officer and a director of Thomson Reuters Corporation. 

“Since Tom joined our board in 2007, his expertise, counsel, and guidance have been invaluable to our company. Tom is a strategic, insightful, and accomplished corporate leader, and I look forward to our continued collaboration and partnership as we continue to deliver value to our stakeholders and ensure the short- and long-term success of our company,” stated Rob Davis, chief executive officer and president, Merck. 

Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the leading edge of research. Merck has the industry’s largest immuno-oncology clinical research program. To learn more about Merck (MRK) and to track its ongoing progress please visit the Vista Partners Merck Coverage Page.

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research. Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

(Read Original Story: Merck Announces Appointment of Thomas H. Glocer as Independent Lead Director in Business Wire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us